Friday, July 4, 2025

Latest
Population Plateau Exposes Developers’ Overdependence on Demand Rising
Alberta, Ontario Pressure Carney To Repeal C-69 and Carbon Tax Laws
Ottawa Waives Inadmissibility Bar for 17,600 Criminal Convictions By Foreign Nationals
Paramount Pays Trump $16 Million to Settle ’60 Minutes’ Lawsuit
US Housing Finance Chief Calls for Powell Investigation, Trump Wants Him to Resign
Microsoft Trims Workforce by 9,000 Amid $80 billion AI Push
EU Lawmakers Streamline Carbon Border Tax, Exempt 90% of Importing Companies
Major Aluminum Investment Signals Confidence Despite US-Canada Trade Dispute
Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill
Marimaca Copper Pauses PEA For Pampa Medina After New Discovery
Search

Kalytera Therapeutics’ statement of loss as of September 30, 2017.

Kalytera Therapeutics' statement of loss as of September 30, 2017.

Kalytera Therapeutics’ statement of loss as of September 30, 2017.

© 2025
the deep dive
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.